Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation

British Journal of Pharmacology

Volumn 134, Issue 3, 2001, Pages 563-570

  Izzo, Angelo A ^a   Fezza, Filomena ^b   Capasso, Raffaele ^c   Bisogno, Tiziana ^b   Pinto, Luisa ^a   Iuvone, Teresa ^a   Esposito, Giuseppe ^a   Mascolo, Nicola ^a   Di Marzo, Vincenzo ^b   Capasso, Francesco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

2 arachidonylglycerol; Anandamide; Cannabinoid receptors; Endocannabinoids; Inflammatory bowel disease; Intestinal motility; Intestine

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; AMIDASE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CROTON OIL; RIMONABANT; TETRAHYDROCANNABINOL; ANALGESIC AGENT; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOL; CYCLOHEXANOL DERIVATIVE; DERMATOLOGICAL AGENT; DRUG RECEPTOR; ENDOCANNABINOID; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; ENTERITIS; ENZYME ACTIVITY; GASTROINTESTINAL MOTILITY; HYDROLYSIS; LYMPHOCYTIC INFILTRATION; MOUSE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SUBMUCOSA; SYNAPTIC TRANSMISSION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANALGESICS; ANIMALS; CANNABINOIDS; CANNABINOL; CROTON OIL; CYCLOHEXANOLS; DERMATOLOGIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; GASTROINTESTINAL MOTILITY; INFLAMMATORY BOWEL DISEASES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0034740564     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704293     Document Type: Article

References (50)

1. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
2. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
3. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
4. Control of pain initiation by endogenous cannabinoids
5. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid
6. Cannabinoid modulation of intestinal propulsion in mice
7. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
8. 1 receptors in human ileum
9. Conformationally restrained analogues of pravadoline: Nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor
10. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
11. Cannabinoid Pharmacology
12. Endocannabinoids: New targets for drug development
13. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
14. 9-tetrahydrocannabinol
15. 2-like cannabinoid receptors on peripheral nerve terminals
16. Pharmacological effects produced by intracerebral injection of drugs in the conscous mouse
17. Cannabinoid inhibition of guineapig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways
18. Effect of vanilloid drugs on gastroitnestinal transit in mice
19. Effect of cannabinoid agonists on intestinal motility in a chronic model of intestinal inflammation
20. 1 receptor
21. 1 receptors
22. Forgotten target for Marijuana: The endocannabinoid system in the gut
23. Marijuana in the new millennium: Perspectives for cannabinoid research
24. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat
25. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
26. 1 ligands in the isolated guinea pig ileum
27. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil
28. Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
29. Hindbrain neuroactive substances controlling gastrointestinal functions
30. 1 receptors
31. 1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system
32. 1 receptors
33. 2 receptors
34. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
35. Identification of an endogenous 2-monoglyceride present in canine gut that binds to a cannabinoid receptor
36. Endocannabinoids
37. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
38. Molecular characterization of a peripheral receptor for cannabinoids
39. 1 cannabinoid receptors
40. Pharmacology of cannabinoid receptor ligands
41. 1 receptors in guinea-pig small intestine
42. Cannabinoid penetration into mouse brain as determined by ex vivo binding
43. 9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors
44. Peripheral effects of opioids in a model of chronic intestinal inflammation in mice
45. Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist
46. 2 cannabinoid receptors
47. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents
48. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
49. Effects of mu-opioid receptor agonists on intestinal secretion and permeability during acute intestinal inflammation in mice